Filing Flows

Filing Flows › Bionano Genomics (BNGO) › Next earnings date

Bionano Genomics (BNGO) earnings on Nov 10, 2026: what to expect

Bionano Genomics (BNGO) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.45 (1 estimate) on revenue of $8.4M, against −$1.59 and $7.4M a year ago. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 85% chance of beating next time.

Report dateNov 10, 2026
Days to go2
EPS estimate−$0.45
Revenue estimate$8.4M
Beat rate100%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Bionano Genomics: revenue lines, growth year over year, Q2 2026Bionano Genomics: revenue lines, growth year over year, Q2 2026Revenue+21%Product+22%Consumable Revenue+31%Instrument Revenue+46%Software Revenue-16%Product and Service Other+13%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$1.59 on revenue of $8.5M, against the analysts' −$0.45.

The last report

Bionano Genomics reported revenue of $8.2M for the second quarter 2026 (+21% Y/Y), net loss $7.4M: Product $7.7M, Product and Service Other $478K. How it makes money → · Every quarter →

Bionano Genomics: EPS against the estimate, last 4 reportsBionano Genomics: EPS against the estimate, last 4 reportsEstimateReported−$2.34−$1.59Nov 25−$4.14−$0.03Mar 26−$0.95−$0.75May 26−$0.67−$0.60Aug 26
Latest (Aug 26): Estimate −$0.67, Reported −$0.60.

Bionano Genomics' latest quarter

Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.

Questions

When does BNGO report earnings?

Bionano Genomics is expected to report on Nov 10, 2026.

What are analysts expecting from Bionano Genomics?

EPS of −$0.45 and revenue of $8.4M for the quarter.

Does Bionano Genomics usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.